你即將離開本站

並前往https://www.malacards.org/card/newborn_respiratory_distress_syndrome?limit%5BClinicalTrial%5D=935&showAll=True

Newborn Respiratory Distress Syndrome disease - MalaCards

47, Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19, Terminated, NCT04325061, Phase 4, Dexamethasone.

確定！ 回上一頁

查詢 「Nct04325061」的人也找了：